The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications - PubMed (original) (raw)
Review
doi: 10.2165/11533280-000000000-00000.
Ka Young Park, Candy W Y Law, Farah Sultan, Amanda Adams, Maria Teresa Lourenco, Aaron K S Lo, Joanna K Soczynska, Hanna Woldeyohannes, Mohammad Alsuwaidan, Jinju Yoon, Sidney H Kennedy
Affiliations
- PMID: 20806987
- DOI: 10.2165/11533280-000000000-00000
Review
The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications
Roger S McIntyre et al. CNS Drugs. 2010 Sep.
Abstract
Major depressive disorder is a prevalent recurrent medical syndrome associated with inter-episodic dysfunction. The metabolic syndrome is comprised of several established risk factors for cardiovascular disease (i.e. abdominal obesity, dyslipidaemia, dysglycaemia and hypertension). The criterion items of the metabolic syndrome collectively represent a multi-dimensional risk factor for cardiovascular disease and type 2 diabetes mellitus. Extant evidence indicates that both major depressive disorder and the metabolic syndrome, albeit distinct, often co-occur and are possibly subserved by overlapping pathophysiology and causative mechanisms. Conventional antidepressants exert variable effects on constituent elements of the metabolic syndrome, inviting the need for careful consideration prior to treatment selection and sequencing. Initiating and maintaining antidepressant therapy should include routine surveillance for clinical and/or biochemical evidence suggestive of the metabolic syndrome.
Similar articles
- Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome.
Kemp DE, Ismail-Beigi F, Calabrese JR. Kemp DE, et al. Am J Psychiatry. 2009 May;166(5):619. doi: 10.1176/appi.ajp.2008.08081195. Am J Psychiatry. 2009. PMID: 19411385 Free PMC article. No abstract available. - Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
Pae CU, Lim HK, Han C, Patkar AA, Steffens DC, Masand PS, Lee C. Pae CU, et al. Expert Rev Neurother. 2007 Oct;7(10):1251-63. doi: 10.1586/14737175.7.10.1251. Expert Rev Neurother. 2007. PMID: 17939764 Review. - Second-generation antidepressants for depression in adults.
Seehusen DA, Sheridan R. Seehusen DA, et al. Am Fam Physician. 2013 Nov 15;88(10):687-9. Am Fam Physician. 2013. PMID: 24364484 Review. No abstract available. - Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.
Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN. Gartlehner G, et al. Ann Intern Med. 2011 Dec 6;155(11):772-85. doi: 10.7326/0003-4819-155-11-201112060-00009. Ann Intern Med. 2011. PMID: 22147715 Review. - Choosing a second generation antidepressant for treatment of major depressive disorder.
Lester H, Gilbody S. Lester H, et al. BMJ. 2012 Feb 14;344:e1014. doi: 10.1136/bmj.e1014. BMJ. 2012. PMID: 22334542 No abstract available.
Cited by
- Practice and proficiency of Isha Yoga for better mental health outcomes: insights from a COVID-19 survey.
Malipeddi S, Mehrotra S, John JP, Kutty BM. Malipeddi S, et al. Front Public Health. 2024 Feb 2;12:1280859. doi: 10.3389/fpubh.2024.1280859. eCollection 2024. Front Public Health. 2024. PMID: 38371236 Free PMC article. - Metabolic Effects of Antidepressants: Results of a Randomized Study's Interim Analysis.
Santi NS, Biswal SB, Naik BN, Sahoo JP, Rath B. Santi NS, et al. Cureus. 2023 Jul 27;15(7):e42585. doi: 10.7759/cureus.42585. eCollection 2023 Jul. Cureus. 2023. PMID: 37641760 Free PMC article. - Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men.
Lechner K, Heel S, Uhr M, Dose T, Holsboer F, Lucae S, Schaaf L, Fulda S, Kloiber S, Hennings JM. Lechner K, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep;396(9):1999-2008. doi: 10.1007/s00210-023-02448-y. Epub 2023 Mar 9. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36890393 Free PMC article. - Effects of (S)-ketamine on depression-like behaviors in a chronic variable stress model: a role of brain lipidome.
Zhou C, Zhao X, Ma X, Ma H, Li R, Hu G, Wang H, Peng Z, Cai M. Zhou C, et al. Front Cell Neurosci. 2023 Feb 15;17:1114914. doi: 10.3389/fncel.2023.1114914. eCollection 2023. Front Cell Neurosci. 2023. PMID: 36874216 Free PMC article.
References
- J Clin Psychopharmacol. 1986 Feb;6(1):27-32 - PubMed
- Psychiatry Res. 1988 Dec;26(3):265-71 - PubMed
- Circulation. 2002 Dec 17;106(25):3143-421 - PubMed
- Br J Psychiatry. 1973 Nov;123(576):501-7 - PubMed
- Am J Psychiatry. 1991 Apr;148(4):512-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical